| Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis: American College of … S MacLean, S Mulla, EA Akl, M Jankowski, PO Vandvik, S Ebrahim, ... Chest 141 (2), e1S-e23S, 2012 | 327 | 2012 |
| Physician attitudes toward shared decision making: a systematic review S Pollard, N Bansback, S Bryan Patient education and counseling 98 (9), 1046-1057, 2015 | 256 | 2015 |
| In the public interest: assessing expert and stakeholder influence in public deliberation about biobanks S MacLean, MM Burgess Public Understanding of Science 19 (4), 486-496, 2010 | 60 | 2010 |
| The burden of nonadherence among adults with asthma: a role for shared decision‐making S Pollard, N Bansback, JM FitzGerld, S Bryan Allergy 72 (5), 705-712, 2017 | 45 | 2017 |
| Toward the diagnosis of rare childhood genetic diseases: what do parents value most? S Pollard, D Weymann, J Dunne, F Mayanloo, J Buckell, J Buchanan, ... European Journal of Human Genetics 29 (10), 1491-1501, 2021 | 28 | 2021 |
| Balancing uncertainty with patient autonomy in precision medicine S Pollard, S Sun, DA Regier Nature Reviews Genetics 20 (5), 251-252, 2019 | 25 | 2019 |
| A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada DA Regier, S Pollard, M McPhail, T Bubela, TP Hanna, C Ho, HJ Lim, ... NPJ Precision Oncology 6 (1), 76, 2022 | 23 | 2022 |
| Having our “omic” cake and eating it too?: evaluating user response to using Blockchain technology for private and secure health data management and sharing VL Lemieux, D Hofman, H Hamouda, D Batista, R Kaur, W Pan, ... Frontiers in Blockchain 3, 558705, 2021 | 22 | 2021 |
| Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges D Weymann, N Dragojlovic, S Pollard, DA Regier Journal of community genetics 13 (5), 467-476, 2022 | 19 | 2022 |
| Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication S Pollard, S Kalloger, D Weymann, S Sun, J Nuk, KA Schrader, DA Regier Health Expectations 23 (4), 884-892, 2020 | 19 | 2020 |
| Clinical and cost outcomes following genomics‐informed treatment for advanced cancers D Weymann, S Pollard, B Chan, E Titmuss, A Bohm, J Laskin, SJM Jones, ... Cancer Medicine 10 (15), 5131-5140, 2021 | 15 | 2021 |
| Defining a core data set for the economic evaluation of precision oncology S Pollard, D Weymann, B Chan, M Ehman, S Wordsworth, J Buchanan, ... Value in Health 25 (8), 1371-1380, 2022 | 11 | 2022 |
| Developing data sharing models for health research with real-world data: A scoping review of patient and public preferences A Hermansen, DA Regier, S Pollard Journal of Medical Systems 46 (12), 86, 2022 | 7 | 2022 |
| Genomic testing for relapsed and refractory lymphoid cancers: understanding patient values S Costa, DA Regier, AJN Raymakers, S Pollard The Patient-Patient-Centered Outcomes Research 14, 187-196, 2021 | 7 | 2021 |
| Stakeholder perspectives on navigating evidentiary and decision uncertainty in precision oncology S Pollard, J Dunne, S Costa, DA Regier Journal of Personalized Medicine 12 (1), 22, 2022 | 6 | 2022 |
| Biobanks: Informing the public through expert and stakeholder presentations S MacLean, MM Burgess Health L. Rev. 16, 6, 2007 | 5 | 2007 |
| Toward best practices for economic evaluations of tumour-agnostic therapies: A review of current barriers and solutions D Weymann, S Pollard, H Lam, E Krebs, DA Regier Value in Health, 2023 | 4 | 2023 |
| Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach S Pollard, D Weymann, R Loewen, J Nuk, S Sun, KA Schrader, C Hessels, ... Health Expectations, 2023 | 2 | 2023 |
| EXPECT-NLP: An integrated pipeline and user interface for exploring patient preferences directly from patient-generated text D Johnson, N Dragojlovic, N Kopac, Y Chen, M Lenzen, S Le Huray, ... Multimodal AI in healthcare: A paradigm shift in health intelligence, 77-89, 2022 | 2 | 2022 |
| Life-cycle health technology assessment for precision oncology. DA Regier, D Weymann, B Chan, C Ho, HJ Lim, S Yip, R Rittberg, S Sun, ... Journal of Clinical Oncology 40 (16_suppl), e18704-e18704, 2022 | 1 | 2022 |
